GSK plc (GSK)
NYSE·Healthcare·Drug Manufacturers - General
$54.66
+0.81%
Mkt Cap $111.31B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 4, 2026 | $11.41B | $11.78B | +3.23% | $0.64 | $0.68 | +6.25% | — | — |
| Q4 2025 Oct 29, 2025 | $8.48B | $8.55B | +0.78% | $1.26 | $1.48 | +17.46% | — | — |
| Q3 2025 Jul 30, 2025 | — | $10.88B | — | — | $0.96 | — | — | — |
| Q2 2025 Apr 30, 2025 | $7.95B | $9.70B | +22.12% | $1.08 | $1.13 | +4.63% | — | — |
| Q1 2025 Feb 5, 2025 | $9.54B | $10.16B | +6.47% | $0.44 | $0.59 | +34.09% | — | — |
| Q4 2024 Oct 30, 2024 | $10.10B | $10.50B | +3.93% | $1.16 | $1.27 | +9.48% | — | — |
| Q3 2024 Jul 31, 2024 | $9.66B | $9.98B | +3.29% | $1.00 | $1.09 | +9.00% | — | — |
| Q1 2024 Jan 31, 2024 | $9.66B | $9.24B | -4.36% | $0.76 | $0.72 | -5.26% | — | — |
| Q4 2023 Nov 1, 2023 | $9.37B | $10.18B | +8.57% | $1.09 | $1.26 | +15.60% | — | — |
| Q3 2023 Jul 26, 2023 | $8.78B | $9.91B | +12.82% | $0.87 | $0.97 | +11.49% | — | — |
| Q2 2023 Apr 26, 2023 | $8.07B | $9.09B | +12.65% | $0.82 | $0.90 | +9.76% | — | — |
| Q1 2023 Feb 1, 2023 | $8.90B | $8.59B | -3.49% | $0.59 | $0.64 | +8.47% | — | — |
| Q4 2022 Nov 2, 2022 | $8.31B | $9.07B | +9.06% | $0.96 | $1.10 | +14.58% | — | — |
| Q3 2022 Jul 27, 2022 | $7.88B | $8.66B | +9.87% | $0.76 | $0.87 | +14.47% | — | — |
| Q2 2022 Apr 27, 2022 | $11.75B | $8.41B | -28.41% | $0.96 | $1.10 | +14.58% | — | — |
| Q1 2022 Feb 9, 2022 | $12.87B | $9.43B | -26.71% | $0.81 | $0.86 | +6.17% | — | — |
| Q4 2021 Oct 27, 2021 | — | $12.85B | — | $1.00 | $1.26 | +26.00% | — | — |
| Q3 2021 Jul 28, 2021 | — | $8.95B | — | $0.64 | $0.98 | +53.12% | — | — |
| Q2 2021 Apr 28, 2021 | — | $8.07B | — | $0.76 | $0.79 | +3.95% | — | — |
| Q1 2021 Feb 3, 2021 | — | $10.25B | — | $0.80 | $0.77 | -3.75% | — | — |